Salt Lake City, UT (October 26, 2023) 4Life Research and Development scientists published their findings in a peer-reviewed scientific journal: Current Therapeutic Research
. The studies measured the immunomodulatory effects of 4Life Transfer Factor®
and 4Life Transfer Factor products.
Vice President of Product Development Lawry Han, PhD, FACN; Chief Scientific Officer David Vollmer, PhD; and Health Sciences Advisory Board member Elena Y. Enioutina, MD, PhD coauthored the newly published research article: “Immunomodulatory Effects of Modified Bovine Colostrum, Whey, and Their Combination with Other Natural Products: Effects on Human Peripheral Blood Mononuclear Cells.”
Vollmer: “That’s a really long title for findings that are simple, yet important: 4Life Transfer Factor can do more than just boost the immune system. While we’ve demonstrated 4Life Transfer Factor’s immune-activating benefits across many different studies, our latest data reveals that 4Life Transfer Factor can also calm an overactive immune system. This new, independent research has wide-ranging applications across many aspects of wellness, particularly for those who can benefit from balancing the immune system.”
The researchers studied a variety of 4Life proprietary products and formulas: 4Life®
Transfer Factor Plus®
in 4Life Transfer Factor®
Formula in 4Life Transfer Factor Plus Tri-Factor Formula, the super-mushroom blend in the botanical blend of 4Life Transfer Factor Plus Tri-Factor Formula, and the whey protein concentrate in NutraStart®
All ingredients studied showed positive effects in modulating innate and adaptive immune cell activity.
4Life, The Immune System Company®
, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.
For more information:
Vice President Corporate Communications